1[1]Kannel WB.Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevations to cardiovascular risk profile.Circulation,1999,100:354-360.
2[2]Domanski M J,Davis BR,Pfeffer MA,et al.Isolated systolic hypertension:prognostic information provided by pulse pressure.Hypertension,1999,34:375-380.
3[3]Wang JC,Staessen JA,Gong L,et al.Chinese trial on isolated systolic hypertension in the elderly.Systolic hypertension in China (syst-China) collaborative group.Arch Intern Med,2000,160:211-220.
5[5]Meaume S,Rudnichi A,Lyneh A,et al.Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive pations.Hypertens,2001,19:871-877.
6[6]Svolainen A,Kupari M,Keto P,et al.Effects of angiotensin converting enzyme inhibitor versus beta-adrenergic blockade on aortic stiffness in essential hypertension.Eur Heart J,1994,15:448.
7[7]Asmar G,London M,O'Rourke E,et al.Improvement in blood pressure,arterial stiffness and wave reflections with a very-lowdose perindopril indapamide combination in hypertensive patient:a comparison with atenolo.Hypertension,2001,38:922-926.
9[9]Wilkinson B,Qasem A,Mceniery M,et al.Nitric oxide regulates local arterial distensibility in vivo.Circulation,2002,105:213-217.
10[10]Wang H,Hu D,Sun N,et al.Effect of long-acting isosorbide-5-mononitrate administration on large artety distensibility in patients with essential hypertension.Hypertens Res,2001,24:311-314.
二级参考文献48
1Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determincs cardiovascular risk in older hypertensive patients. Arch Intern Meal, 2000, 160: 1065-1069.
2Blaeher J, Asmar R, Diane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension, 1999, 33: 1111-1117.
3de Simone G, Roman MJ, Koren MJ, et al. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension, 1999, 33:800-805.
4Baeher J, Pannier B, Guerin A, et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension, 1998, 32: 570-574.
5Meaume S, Rudnichi A, Lynch A, et al. Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old. J Hypertens, 2001, 19: 871-877.
6Blatcher J, Guerln AP, Pannier B, et al. Impact of aortic stiffneas on survival in end-stage renal disease. Circulation, 1999, 99 : 2434-2439.
7O'Rourke MF, Hayward CS, Lehman ED. Arterial stiffness. In: Oparil S, Weber MA ,eds. Hypertension: a companion to Brenner & Rector's kidney. Philadelphia: Saunders, 2000. 134-151.
8Nichols WW, O'Rourke M. McDonald' s blood flow in arteries. Theoretical, experimental aud clinical principles. 4th ed. London: Arnold Hodder Headline Group, 1998.
9Wang H, Hu D, Sun N, et al. Effect of long-acting isosorbide-5-mononitrate administration on large artery distensibility in patients with essential hypertension. Hypertens Res, 2001, 24: 311-314.
10Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation, 1999, 100: 354-360.
